Literature DB >> 8513842

Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery.

H Quiding1, G Lundqvist, L O Boréus, U Bondesson, J Ohrvik.   

Abstract

A double blind randomised cross over investigation was carried out in 25 male patients undergoing two oral surgical extractions, one for each lower wisdom tooth. The two extractions were performed about 6 weeks apart and were carried out under local anaesthesia. One hour after each extraction the patients randomly received 90 or 45 mg codeine. During the following 5 h the patients rated the intensity of their pain on a visual analogue scale. Blood was simultaneously sampled and assayed for codeine and its metabolite morphine. Mean pain intensity difference was just significantly higher after 90 mg codeine compared to 45 mg. The mean plasma concentrations of codeine and morphine were significantly higher after the 90 mg dose. However, for the two dose levels of codeine there was no obvious relationship between the difference in analgesic effect and the difference in the plasma concentration of codeine or morphine. The plasma concentrations of morphine were 2-3% of those of codeine and the levels were relatively low. Local formation of morphine from codeine within the human brain should therefore be investigated. Four patients were unable to demethylate codeine to a detectable plasma concentration of morphine after 90 mg codeine. In those patients the analgesic effect during the first hours was better after 90 mg codeine than after 45 mg. This suggests some analgesic effect of codeine itself.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513842     DOI: 10.1007/BF00316466

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  26 in total

1.  [Not Available].

Authors:  G SANFILIPPO
Journal:  Boll Soc Ital Biol Sper       Date:  1948-06

2.  Polymorphic O-demethylation of codeine.

Authors:  Z R Chen; A A Somogyi; F Bochner
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

3.  Analgesic activity of morphine-6-glucuronide.

Authors:  R Osborne; S Joel; D Trew; M Slevin
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

4.  Plasma codeine and morphine concentrations after a single oral dose of codeine phosphate.

Authors:  J C Shah; W D Mason
Journal:  J Clin Pharmacol       Date:  1990-08       Impact factor: 3.126

5.  Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine.

Authors:  S H Sindrup; K Brøsen; P Bjerring; L Arendt-Nielsen; U Larsen; H R Angelo; L F Gram
Journal:  Clin Pharmacol Ther       Date:  1990-12       Impact factor: 6.875

6.  Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI).

Authors:  P Dayer; J Desmeules; T Leemann; R Striberni
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

7.  Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations.

Authors:  G Alván; P Bechtel; L Iselius; U Gundert-Remy
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  The effect of quinidine on the analgesic effect of codeine.

Authors:  S H Sindrup; L Arendt-Nielsen; K Brøsen; P Bjerring; H R Angelo; B Eriksen; L F Gram
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers.

Authors:  M Vater; G Smith; G W Aherne; A R Aitkenhead
Journal:  Br J Anaesth       Date:  1984-08       Impact factor: 9.166

10.  Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.

Authors:  Q Y Yue; J Hasselström; J O Svensson; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

View more
  3 in total

Review 1.  Role of active metabolites in the use of opioids.

Authors:  Janet K Coller; Lona L Christrup; Andrew A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  2008-10-29       Impact factor: 2.953

Review 2.  Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.

Authors:  Jörn Lötsch; Carsten Skarke; Jürgen Liefhold; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Codeine and clinical impairment in samples in which morphine is not detected.

Authors:  Liliana Bachs; Svetlana Skurtveit; Jørg Mørland
Journal:  Eur J Clin Pharmacol       Date:  2003-03-01       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.